Us Congress 2025-2026 Regular Session

Us Congress Senate Bill SB186

Introduced
1/22/25  

Caption

No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025

Impact

The implications of SB186 extend to the Affordable Care Act (ACA) as it specifies clarifications regarding how federal funding restrictions would apply to premium tax credits and cost-sharing reductions. By doing so, it seeks to eliminate federal subsidies for health plans that include abortion coverage, thereby limiting access to such services for individuals seeking insurance through the ACA. This not only affects individual choices regarding health coverage but also imposes significant changes on health insurers regarding what they can offer.

Summary

SB186, known as the 'No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025', aims to prohibit the use of taxpayer funds for abortion services. The bill introduces several provisions, asserting that no federal funds can be used directly or indirectly for any abortion services. It amends the United States Code to establish strict regulations around abortion funding, especially within federally operated health care facilities and among federally employed medical professionals. This legislation is designed to tighten existing restrictions on federal funding related to abortion services and health plans that cover abortions.

Contention

The introduction of SB186 is likely to ignite considerable debate, especially from various interest groups and legislators with divergent views on abortion. Supporters of the bill argue that taxpayer funds should not be allocated for abortions, promoting the notion of fiscal responsibility and aligning with the beliefs of those who oppose abortion on moral or ethical grounds. Conversely, opponents criticize the bill as an excessive limitation on women's rights and access to necessary health care. They highlight potential negative consequences for low-income individuals and marginalized groups who may be disproportionately affected by the lack of access to abortion services. This polarization underscores the ongoing contentious nature of abortion-related legislation in the United States.

Congress_id

119-S-186

Policy_area

Health

Introduced_date

2025-01-22

Companion Bills

US HB7

Same As No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025This bill modifies provisions relating to federal funding for, and health insurance coverage of, abortions.Specifically, the bill prohibits the use of federal funds for abortions or for health coverage that includes abortions. Such restrictions extend to the use of funds in the budget of the District of Columbia. Additionally, abortions may not be provided in a federal health care facility or by a federal employee.Historically, language has been included in annual appropriations bills for the Department of Health and Human Services (HHS) that prohibits the use of federal funds for abortions—such language is commonly referred to as the Hyde Amendment. Similar language is also frequently included in appropriations bills for other federal agencies and the District of Columbia. The bill makes these restrictions permanent and extends the restrictions to all federal funds (rather than specific agencies).The bill's restrictions regarding the use of federal funds do not apply in cases of rape, incest, or where a physical disorder, injury, or illness endangers a woman's life unless an abortion is performed. The Hyde Amendment provides the same exceptions.The bill also prohibits qualified health plans from including coverage for abortions. Currently, qualified health plans may cover abortion, but the portion of the premium attributable to abortion coverage is not eligible for subsidies.

Similar Bills

US SB382

Dismantle DEI Act of 2025

US HB2202

End Taxpayer Funding of Gender Experimentation Act of 2025

US HB2114

Block Organ Transplant Purchases from China Act of 2025

US HB328

REVOCAR Act of 2025 Revoke Exemptions for Venezuelan Oil to Curb Autocratic Repression Act of 2025

US SB1096

Preserve Access to Affordable Generics and Biosimilars Act

US SB985

PROTECT USA Act of 2025 Prevent Regulatory Overreach from Turning Essential Companies into Targets Act of 2025

US HB358

No Corruption in Government Act Prohibit Insider Trading Act

US SB986

Safe Schools Improvement Act